PROTOCOL N01394: A RANDOMIZED, OPEN-LABEL, MULTICENTER, PARALLEL-GROUP, EXPLORATORY STUDY TO EVALUATE THE EFFICACY OF INTRAVENOUS BRIVARACETAM AND INTRAVENOUS PHENYTOIN IN SUBJECTS EXPERIENCING NONCONVULSIVE ELECTROGRAPHIC SEIZURES

Grants and Contracts Details

StatusFinished
Effective start/end date6/14/13 → 5/31/15

Funding

  • UCB Pharma (domestic): $17,306.00